Edwards Lifesciences Corporation Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.07 (market cap $48.56B), while SPDR Kensho Final Frontiers ETF trades at $102.69 (market cap $170.14M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 285.4× SPDR Kensho Final Frontiers ETF's market cap, and SPDR Kensho Final Frontiers ETF is more actively traded (12,298 versus 6,520,488). Which is the better fit depends on your goals.
| EW | ROKT | |
|---|---|---|
Market Cap | $48.56B | $170.14M |
Volume | 6,520,488 | 12,298 |
Sector | Health | Sector/Thematic |
52-Week High | $95.18 | $136.68 |
52-Week Low | $72.65 | $72.93 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 8 Days |
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →